Alembic Pharmaceuticals consolidated net profit rises 29.20% in the March 2026 quarter

Sales rise 4.41% to Rs 1847.72 crore

Net profit of Alembic Pharmaceuticals rose 29.20% to Rs 202.70 crore in the quarter ended March 2026 as against Rs 156.89 crore during the previous quarter ended March 2025. Sales rose 4.41% to Rs 1847.72 crore in the quarter ended March 2026 as against Rs 1769.64 crore during the previous quarter ended March 2025.

For the full year,net profit rose 15.66% to Rs 674.77 crore in the year ended March 2026 as against Rs 583.42 crore during the previous year ended March 2025. Sales rose 10.08% to Rs 7344.90 crore in the year ended March 2026 as against Rs 6672.08 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	1847.72	1769.64	4	7344.90	6672.08	10
OPM %	12.34	15.33	-	15.23	15.11	-
PBDT	231.97	260.93	-11	1079.49	972.89	11
PBT	143.38	191.94	-25	760.94	694.31	10
NP	202.70	156.89	29	674.77	583.42	16

Powered by Capital Market - Live News